Beruflich Dokumente
Kultur Dokumente
Bilal Al-Jaidi
Assistant Professor in Medicinal Chemistry and Drug Design
Faculty of Pharmacy, Philadelphia University-Jordan
Email: bjaidi@philadelphia.edu.jo
Learning Outcomes
At the end of this lesson, students will be able to:
Define the biochemistry of Parasympathetic system.
Classify the difference between agonist and antagonist
agents
Outline the SAR of acetylcholine.
Demonstrate the different chemical modification of
Acetylcholine.
Explain the importance of Cholinergic agonists and
antagonists in disease management.
Demonstrate the action of AchE inhibitors in the
management of Parkinson.
Overview of Nervous System
Parasympathetic Responses
Motor nerves
Without motor nerves:
No breathing.
Digestion.
Excretion.
Muscle movement.
Control of body temperature.
Heart problems.
Motor nerves
1. Somatic motor NS:
carry messages from CNS to the skeletal muscles.
Acetylcholine is the neurotransmitter.
Fight or Flight
Motor nerves
3. Enteric NS:
Located in the wall of intestine.
Use serotonin, neuropeptide, Acetylcholine and
Dopamine are among many other neurotransmitters
take part in this system
Nerve Impulse Transmission
Nerve Impulse Transmission
Acetylcholine combines with cholinergic
receptors
Nicotinic
Excitatory response
Muscarinic
Excites or inhibits
SAR for acetylcholine
O O
CMe3 NMe2
H3C O H3C O
O O
H 3C O H 3C O NMe3
NMe3
Ester is important
NMe3 NMe3
H 3C O H 3C
O Et
O Et
N Me
N Et H 3C O
H 3C O Me
Et
H 3C NMe3
O
Conclusions:
• Tight fit between Ach and binding site
• Methyl groups fit into small hydrophobic pockets
• Ester interacting by H-bonding
• Quaternary nitrogen interacting by ionic bonding
Binding site (muscarinic)
hydrophobic
pocket Trp-307
Asp311
CH3 CH3
CO 2
N CH3
hydrophobic
O O
pockets
CH3
Trp-616 Trp-613
H
H
O N hydrophobic
pocket
Asn-617
Binding site (muscarinic)
vdw Trp-307
Asp311
CH3 CH3
CO 2
Ionic bond
N CH3 vdw
O O
H-bonds CH3 vdw
Trp-616 Trp-613
H
H
O N
Asn-617
Cholinergic Agents
Direct acting - act on the receptors to activate a tissue
response
Indirect acting - inhibit the action of the enzyme
Acetylcholinesterase:
Acetyl Choline
Cholinergic receptors
1. Muscarinic receptors:
Found in smooth muscles and cardiac muscles.
Related to muscarine.
2. Nicotinic receptors:
Found in skeletal muscles.
Related to nicotine.
Subtypes of M1 M2 M3 M4 M5
M- receptor Neural Cardiac Glandular,
smooth muscles
Main CNS, Gastric & Heart , GIT, Gastric & CNS CNS
location salivary glands CNS salivary glands,
GIT, Eye
Cellular Increase IP3, Decrease in Increase IP3, As M2 As M3
response DAG, a) cAMP Ca++
Depolarization, inhibition, conductance,
excitation, b) Ca++
increase conductance,
potassium
conductance Increase K+
conductance
Functional CNS excitation, Cardiac Gastric & saliva Enhanced Not
responses gastric secretion inhibition, secretion, GI locomotion
known
neural smooth muscle
inhibition contraction,
occular
accomodation
Cholinergic agonists
Acetylcholine as an agonist
Advantages
• Natural messenger
• Easily synthesised
Disadvantages
• Easily hydrolysed in stomach (acid catalysed hydrolysis)
• Easily hydrolysed in blood (esterases)
• No selectivity between receptor types
• No selectivity between different target organs
L-serine ethanolamine
choline Acetylcholine
Biological hydrolysis of Ach
Advantages
Disadvantages
• Activate receptors for other chemical messengers
• Side effects
Cholinergic agonists
4.4A 5.9A
O O
N N
Muscarinic
Nicotinic
receptor
receptor
Uses of cholinergic agonists
More stable.
More selective on muscarinic receptor.
Used to stimulate GIT and urinary bladder
after surgery.
Muscarinic agonists
Clinical uses:
Treatment of glaucoma.
Stimulate GIT and UT after surgery.
In some heart defects.
Pilocarpine:
Me
N
HO Me
H CH2
O
CH2
H
Me
O
H N OH
OMe
What do we mean by Antagonists
Antagonist is a molecule that can bind to a
receptor without eliciting a response:
Clinical uses:
easily racem
Atropine
O CH3
C
O
N N
N
C O
CH2
CH
N
Benzhexol Pirenzepine
(Parkinsons disease) N
(anti-ulcer)
Me
Tropicamide
Cyclopentolate
Important features
• Tertiary amine (ionised) or a quaternary nitrogen
• Aromatic ring
• Ester
• N-Alkyl groups (R) can be larger than methyl (unlike agonists)
• Large branched acyl group
• R’ = aromatic or heteroaromatic ring
• Branching of aromatic/heteroaromatic rings is important
Muscarinic Antagonists
SAR for Antagonists
Me Me
CH O
Me
O CH2CH2 N CH C
O C Me
Me CH2 O CH2 CH2NR2
O
Cl
Active Inactive
Proposed Binding Site for Antagonists
C O
O
H2N Asn
CH2
CH2
NMeR2
CO 2
Nicotinic Antagonists
Curare
Me
N
HO Me
H CH2
O
CH2
H
Me
O Tubocurarine
H N OH
OMe
Native Indians hunting animals with this poison
were able to eat the animal's contaminated flesh
without being affected by the toxin because
tubocurarine cannot easily cross mucous
membranes and is thus inactive orally.
Nicotinic Antagonists
Pharmacophore
Clinical uses
• Long lasting
• Long recovery times
• Side effects on heart
• No longer in clinical use
• Esters incorporated
• Shorter lifetime (5 min)
• Fast onset and short duration
• Frequently used during intubation
• Side effects at autonomic ganglia
Nicotinic Antagonists
Analogues of tubocurarine
• In the US, Pancuronium (Pavulon) is the second of three drugs used in execution by
lethal injection
Nicotinic Antagonists
Analogues of tubocurarine
Tetraalkylammonium ion
Bind to anionic site and block Ach binding
Reversible
Anticholinesterase agents
Anticholinesterase agents
Either reversible or irreversible inhibition.
1. Carbamate:
Organophosphates
Irreversible binding to Cholinesterase active site
Longer acting
Used in the treatment of glaucoma
Irreversible Acetylcholinesterase inhibitors
Organophosphates Insecticides
Irreversible binding to AChE
Rapidly inactivated in mammals compared to insects
Carboxyesterase
Mammals, Birds
Antidote for AchE “poisoning”
Pralidoxime chloride
(Protopam;PAM)
Antidote for pesticide or
nerve gas poisoning
Most effective if given
Cl- within a few hours of
exposure
Clinical Uses of acetylcholinesterase
inhibitors
1. An introduction to Medicinal Chemistry by Graham L. Patrick.
4th edition, Oxford, 2009
2. Wilson and Gisvolds text book of organic medicinal and
pharmaceutical chemistry by John H. Black and John M. Beale,
jr. 12th edition, Lippincott Williams and Wilkings 2011.
3. Foyes principle of medicinal chemistry by David H. Williams,
Thomas L. Leuke, Williams O. Foye. Lippincott William and
Wilkins. 7th edition, 2013.
The End